Economic Evaluation of Systemic Treatments for Cytomegalovirus Retinitis in Patients with AIDS

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.5, 2001-01, pp. : 535-550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand: A Simulation Study

By Teerawattananon Kanlaya

PharmacoEconomics, Vol. 25, Iss. 5, 2007-01 ,pp. : 413-428

Adis International

Access to resources Recommend Favorite

Cidofovir: A Review of its Use in Cytomegalovirus Retinitis in Patients with AIDS

By Plosker G.L. Noble S.

Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. : 325-345

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Analysis of 3 Treatment Strategies for Cytomegalovirus Retinitis in Patients with AIDS

By Griffiths R.I.

PharmacoEconomics, Vol. 13, Iss. 4, 1998-04 ,pp. : 461-474

Adis International

Access to resources Recommend Favorite

Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS

By Rachlis A.

PharmacoEconomics, Vol. 16, Iss. 1, 1999-07 ,pp. : 71-84

Adis International

Access to resources Recommend Favorite

Therapeutic developments in cytomegalovirus retinitis

By Hoffman V.F. Skiest D.J.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 2, 2000-02 ,pp. : 207-220

Informa Healthcare

Access to resources Recommend Favorite